CareDx, Inc (CDNA)
USD 20.4
(-7.86%)
USD 20.4
(-7.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -89.65 Million USD | -6.13% |
| 2022 | -61.22 Million USD | -159.25% |
| 2021 | -17.84 Million USD | -83.92% |
| 2020 | -10.2 Million USD | 34.73% |
| 2019 | -19 Million USD | -68.61% |
| 2018 | -11.36 Million USD | 20.95% |
| 2017 | -14.6 Million USD | 30.13% |
| 2016 | -17.84 Million USD | -119.03% |
| 2015 | -11.26 Million USD | -892.18% |
| 2014 | 523 Thousand USD | -532.99% |
| 2013 | -194 Thousand USD | 84.72% |
| 2012 | -1.27 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -10.49 Million USD | -704.42% |
| 2024 Q2 | 927 Thousand USD | 106.57% |
| 2024 Q1 | -14.11 Million USD | 33.52% |
| 2023 Q1 | -24.33 Million USD | -27.13% |
| 2023 Q2 | -20.95 Million USD | 13.9% |
| 2023 Q4 | -20.87 Million USD | 12.13% |
| 2023 Q3 | -23.75 Million USD | -13.38% |
| 2023 FY | - USD | -6.13% |
| 2022 Q4 | -19.13 Million USD | -46.89% |
| 2022 FY | - USD | -159.25% |
| 2022 Q1 | -15.54 Million USD | -0.59% |
| 2022 Q2 | -18.11 Million USD | -16.53% |
| 2022 Q3 | -13.02 Million USD | 28.08% |
| 2021 FY | - USD | -83.92% |
| 2021 Q1 | 1.74 Million USD | 167.99% |
| 2021 Q4 | -15.45 Million USD | -166.7% |
| 2021 Q3 | -5.79 Million USD | -215.63% |
| 2021 Q2 | -1.83 Million USD | -205.4% |
| 2020 Q2 | -3.05 Million USD | 2.02% |
| 2020 FY | - USD | 34.73% |
| 2020 Q1 | -3.11 Million USD | 47.01% |
| 2020 Q4 | -2.56 Million USD | -371.82% |
| 2020 Q3 | -543 Thousand USD | 82.21% |
| 2019 Q4 | -5.87 Million USD | 38.98% |
| 2019 Q2 | -4.27 Million USD | -248.61% |
| 2019 FY | - USD | -68.61% |
| 2019 Q1 | -1.22 Million USD | 51.12% |
| 2019 Q3 | -9.63 Million USD | -125.39% |
| 2018 Q4 | -2.5 Million USD | -43.72% |
| 2018 FY | - USD | 20.95% |
| 2018 Q3 | -1.74 Million USD | 48.56% |
| 2018 Q2 | -3.39 Million USD | 50.56% |
| 2018 Q1 | -6.86 Million USD | -84.68% |
| 2017 Q1 | -6.55 Million USD | -47.06% |
| 2017 FY | - USD | 30.13% |
| 2017 Q4 | -3.71 Million USD | -39.24% |
| 2017 Q3 | -2.66 Million USD | 9.99% |
| 2017 Q2 | -2.96 Million USD | 54.81% |
| 2016 Q2 | -10.34 Million USD | -9.56% |
| 2016 Q1 | -9.43 Million USD | -148.24% |
| 2016 FY | - USD | -119.03% |
| 2016 Q3 | -5.17 Million USD | 49.92% |
| 2016 Q4 | -4.46 Million USD | 13.87% |
| 2015 Q1 | -1.73 Million USD | -444.33% |
| 2015 FY | - USD | -892.18% |
| 2015 Q4 | -3.8 Million USD | -3.71% |
| 2015 Q3 | -3.66 Million USD | -40.89% |
| 2015 Q2 | -2.6 Million USD | -50.23% |
| 2014 FY | - USD | -532.99% |
| 2014 Q2 | -345 Thousand USD | -185.12% |
| 2014 Q4 | 503 Thousand USD | 143.4% |
| 2014 Q3 | -1.15 Million USD | -235.94% |
| 2014 Q1 | -121 Thousand USD | -119.15% |
| 2013 Q3 | -207 Thousand USD | -125.0% |
| 2013 Q1 | -527 Thousand USD | 0.0% |
| 2013 FY | - USD | 84.72% |
| 2013 Q2 | -92 Thousand USD | 82.54% |
| 2013 Q4 | 632 Thousand USD | 405.31% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 58.027% |
| Prenetics Global Limited | -47.89 Million USD | -87.191% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -5214.582% |
| Exact Sciences Corporation | 41.87 Million USD | 314.101% |
| Exagen Inc. | -19.15 Million USD | -368.109% |
| Inotiv, Inc. | -26.5 Million USD | -238.252% |
| Guardant Health, Inc. | -433.3 Million USD | 79.309% |
| Biodesix, Inc. | -37.1 Million USD | -141.644% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -3507.694% |
| Precipio, Inc. | -4.31 Million USD | -1976.355% |
| iSpecimen Inc. | -9.1 Million USD | -884.839% |
| Natera, Inc. | -383.27 Million USD | 76.608% |
| Aspira Women's Health Inc. | -16.49 Million USD | -443.672% |
| Standard BioTools Inc. | -54.45 Million USD | -64.638% |
| 23andMe Holding Co. | -291.87 Million USD | 69.282% |
| Castle Biosciences, Inc. | -45.02 Million USD | -99.132% |
| Personalis, Inc. | -96.8 Million USD | 7.386% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 23.738% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -834.799% |
| OpGen, Inc. | -29.51 Million USD | -203.809% |
| T2 Biosystems, Inc. | -43.87 Million USD | -104.346% |
| Myriad Genetics, Inc. | -67.8 Million USD | -32.237% |
| ICON Public Limited Company | 1.63 Billion USD | 105.495% |
| NeoGenomics, Inc. | -17.6 Million USD | -409.212% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -5214.582% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 107.363% |
| RadNet, Inc. | 292.78 Million USD | 130.622% |
| MDxHealth SA | -30.46 Million USD | -194.266% |
| Psychemedics Corporation | -251 Thousand USD | -35619.92% |
| Illumina, Inc. | -608 Million USD | 85.254% |
| Check-Cap Ltd. | -17.64 Million USD | -408.0% |
| Twist Bioscience Corporation | -176.7 Million USD | 49.262% |
| DarioHealth Corp. | -53.49 Million USD | -67.602% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -92.595% |
| Sera Prognostics, Inc. | -35.28 Million USD | -154.079% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -816.288% |
| OPKO Health, Inc. | -65.51 Million USD | -36.847% |
| Medpace Holdings, Inc. | 363.15 Million USD | 124.688% |
| Neogen Corporation | 182.59 Million USD | 149.101% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -917.591% |
| Prenetics Global Limited | -47.89 Million USD | -87.191% |
| Mainz Biomed B.V. | -25.01 Million USD | -258.467% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -1075.166% |
| Trinity Biotech plc | -24.09 Million USD | -272.052% |
| Neuronetics, Inc. | -22.75 Million USD | -293.941% |
| Sotera Health Company | 514.14 Million USD | 117.438% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -1075.166% |